Hospital

Antibodies from an original COVID-19 vaccination may treat the mRNA booster vaccine as a virus that needs to be cleared.

The latest data indicate that the formulation can provide up to 6 months of full protection against multiple virus challenges.

The risk of new-onset cardiometabolic diseases was significantly elevated post-COVID-19 infection compared to pre-COVID-19 infection.

Health care providers prescribe naloxone to 1 in every 70 patients prescribed a high-dose opioid medication.

Arrhythmia was found to be the most common cardiovascular complication of COVID-19.

Matt Gibbs, president of Capital Rx, discusses alternative career paths in independently owned PBMs.

As of November 2022, amoxicillin suspension has been on a national shortage list, therefore the FDA has permitted temporary compounding of amoxicillin suspensions.

Pharmacies have long embraced innovation and technology, with early adoption of telehealth and digital platforms.

Patients with heart failure are at a significant risk of cardiorenal diseases, highlighting the need for improved treatments and cost management.

Link between male or female sex and the severity of COVID-19 may be found in a subset of regulatory T cells.

More than 90 minutes of varied sleep time may also increase a person’s risk of developing hardened arteries.

New data identifying a particular gene expression signature will be presented at the 2023 ASCO Genitourinary Symposium.

Under the EUA, the Xpert Mpox test is considered authorized for use in moderately complex point-of-care settings using the GeneXpert Xpress system.

Data from 52 studies show that antimicrobial stewardship programs largely reduced antibiotic use for pediatric care.

The drive for personalized approaches to cancer have helped to create treatments for patients with rare cancers who have few, if any, options.

Idecabtagene vicleucel prolonged progression-free survival by more than 1 year in a difficult-to-treat patient population with relapsed or refractory multiple myeloma.

Association of Black Health-System Pharmacists focuses on advocacy, collaboration, education, leadership, and research.

Relative efficacy of nirmatrelvir–ritonavir appears similar across risk groups, but older adults at risk of severe COVID-19 may benefit more.

Study findings confirmed that in asthma, chronic obstructive pulmonary disease, HIV, and influenza, census data differed from the epidemiological data.

Although investigative team is predominantly investigating Priscilicidin for topical applications, they are not ruling out potential oral applications.

Amanda Ryan, the director of Education for the Pharmacy Quality Alliance (PQA), discusses a new PQA program to teach pharmacy and other health professions students the basics of quality measurement and strategies to improve medication safety, adherence and appropriate use.

The patient's list of medications reveals significant drug interactions to be addressed.

Study shows no robust differences in blood pressure, heart rate, lipids, and glucose measurements in children conceived using assisted reproductive technologies.

Investigators focus on whether legalization of the drug is associated with an increase in health care use for the psychotic disorder.

Streptolysin O appears to influence the pathogenesis of Streptococcus group A and direct mutation-mediated virulence in a host.

The association with subgroups of gene variations based on expression or function should be assessed in larger studies, investigators say.

Trial meets its primary endpoint of progression-free survival regardless of mismatch repair status in patients with stage 3 or 4 or recurrent endometrial carcinoma.

By binding to and inhibiting RANKL, denosumab decreases the production and activity of osteoclasts, resulting in reduced bone loss.

New guidance provides recommendations on infection prevention strategies, performance measures, and how to implement these approaches.

Earlier this week, the FDA Oncologic Drugs Advisory Committee also voted 8 to 5 in support of data for dostarlimab-gxly in rectal cancer.